Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Shawe-Taylor

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Digital Health|August 21, 2023
Biometric linkage of longitudinally collected electronic case report forms and confirmation of subject identity: an open framework for ODK and related toolsChrissy H Roberts, Callum Stott, Marianne Shawe-Taylor, et al.
Peptides|April 2, 2017
Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathwayMarianne Shawe-Taylor, J Dinesh Kumar, Whitney Holden, et al.
ESC Heart Failure|June 7, 2024
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculatorAderonke Abiodun, Marianne Shawe-Taylor, Sara Tyebally, et al.
The Journal of Infection|March 15, 2021
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rateZain Chaudhry, Marianne Shawe-Taylor, Tommy Rampling, et al.
Bioinformatics Advances|October 14, 2024
Chronogram: an R package for data curation and analysis of infection and vaccination cohort studiesDavid Greenwood, Marianne Shawe-Taylor, Hermaleigh Townsley, et al.
Open Forum Infectious Diseases|August 8, 2024
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With MpoxClare E Warrell, Zain Chaudhry, Marianne Shawe-Taylor, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Digital Health|August 21, 2023
Biometric linkage of longitudinally collected electronic case report forms and confirmation of subject identity: an open framework for ODK and related toolsChrissy H Roberts, Callum Stott, Marianne Shawe-Taylor, et al.
Peptides|April 2, 2017
Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathwayMarianne Shawe-Taylor, J Dinesh Kumar, Whitney Holden, et al.
ESC Heart Failure|June 7, 2024
Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculatorAderonke Abiodun, Marianne Shawe-Taylor, Sara Tyebally, et al.
The Journal of Infection|March 15, 2021
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rateZain Chaudhry, Marianne Shawe-Taylor, Tommy Rampling, et al.
Bioinformatics Advances|October 14, 2024
Chronogram: an R package for data curation and analysis of infection and vaccination cohort studiesDavid Greenwood, Marianne Shawe-Taylor, Hermaleigh Townsley, et al.
Open Forum Infectious Diseases|August 8, 2024
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With MpoxClare E Warrell, Zain Chaudhry, Marianne Shawe-Taylor, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
The Lancet. Oncology|March 10, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registryAlessio Cortellini, Josep Tabernero, Uma Mukherjee, et al.
Pageof 1